Heart and Vascular Clinical Trial - Optimize PK Study

Indication for use: The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, including patients with non-ST elevation MI due to discrete de novo native coronary artery lesions. The treated lesion length should be less than the nominal stent length with a reference vessel diameter of 2.25 mm - 4.00 mm

Drug

Device: DES

Trial Type

Interventional

Age Range

18 years or older

Condition

Cardiovascular Heart and vascular Acute Coronary Syndrome

Keywords

Acute Coronary Syndrome | Optimize PK Study | Svelte Medical Systems, Inc.